Search  in | Advanced
   Print  

AABB Regulatory Update Archive

Available exclusively online, Regulatory Update keeps you informed about regulatory issues and legislation affecting facility operations.  Topics include:  FDA/CBER activities; CMS, regarding reimbursement for blood and blood components; CDC, concerning diseases that may be transmissible by blood; DOT, as it affects the transporting of blood; CLIA; DOL/OSHA; relevant Federal Register notices; newly published guidances; safety concerns; and upcoming regulatory meetings.  “Regulatory Developments in Brief,” a feature of Regulatory Update, was published twice per month.


View archived issues 2006 | 20052004 | 2003

Last modified on 6/5/2007 11:37:40 AM
What's New!
AABB Weekly Report - March 12, 2010
Details
National Hemovigilance Program Launches to Track Adverse Events Associated with Blood Transfusion
Details
AABB Statement on XMRV Task Force
Details
Updated Circular of Information for Cellular Therapy Products
Details
Association Bulletin #10-01 - Association Bulletin Listings
Details
Current U.S. Blood Supply is Adequate to Handle Demands Resulting from Earthquake in Haiti
Details
Emerging Infectious Disease Agents
Details
Study Highlights Implications Of Influenza Pandemics On Blood Supplies
Details
Cellular Therapies Subsections
Details
Association Bulletin #09-08 - ISBT 128 Conditional Accreditation Status
Details
AABB Launches Facebook Fan Page
Details